Cargando…

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients

INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Puerta, José A, Celis, Raquel, Hernández, M Victoria, Ruiz-Esquide, Virginia, Ramírez, Julio, Haro, Isabel, Cañete, Juan D, Sanmartí, Raimon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978623/
https://www.ncbi.nlm.nih.gov/pubmed/24485167
http://dx.doi.org/10.1186/ar4372
_version_ 1782310601564880896
author Gómez-Puerta, José A
Celis, Raquel
Hernández, M Victoria
Ruiz-Esquide, Virginia
Ramírez, Julio
Haro, Isabel
Cañete, Juan D
Sanmartí, Raimon
author_facet Gómez-Puerta, José A
Celis, Raquel
Hernández, M Victoria
Ruiz-Esquide, Virginia
Ramírez, Julio
Haro, Isabel
Cañete, Juan D
Sanmartí, Raimon
author_sort Gómez-Puerta, José A
collection PubMed
description INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines in patients with RA according to the presence or absence of ACPA in serum. METHODS: A cross-sectional study in a single center including consecutive RA patients was performed. Patients were defined as 'ACPA negative' if serum was negative to two different ACPAs [second generation commercial anti-cyclic citrullinated peptide antibodies (CCP2) and chimeric fibrin/filaggrin citrullinated antibodies]. Parallel synovial tissue (ST) biopsies and SF were obtained by knee arthroscopy. Synovial cell infiltrate and endothelial cells were analyzed by immunohistochemistry and SF levels of Th1, Th2, Th17 and pro-inflammatory cytokines by Quantibody(R) Human Array. RESULTS: A total of 83 patients underwent arthroscopy, with a mean age of 55.9 ± 12 years, and mean disease duration of 45 months (interquartile range, IQR 10.8 to 122). 62% were female and 77% were ACPA positive. No significant differences were found in clinical variables, acute phase reactants, synovial cell infiltrate or lymphoid neogenesis (LN) between ACPA positive and negative patients. However ACPA positive patients had significantly higher levels of IL-1β, IL-10, IL-17 F and CC chemokine ligand 20 (CCL-20) than ACPA negative patients. CONCLUSIONS: In our cohort of patients with RA no significant differences were found in synovial cell infiltrate or synovial LN according to ACPA status. However, ACPA positive patients had higher levels of T-cell derived and pro-inflammatory cytokines than ACPA negative patients. As systemic and local inflammation was similar in the two groups, these findings support a distinct synovial physiopathology.
format Online
Article
Text
id pubmed-3978623
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39786232014-04-09 Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients Gómez-Puerta, José A Celis, Raquel Hernández, M Victoria Ruiz-Esquide, Virginia Ramírez, Julio Haro, Isabel Cañete, Juan D Sanmartí, Raimon Arthritis Res Ther Research Article INTRODUCTION: Comparative data on synovial cell infiltrate and cytokine levels in anti citrullinated peptide/protein antibody (ACPA)-positive and ACPA negative rheumatoid arthritis (RA) patients are scarce. Our aim was to analyze synovial cell infiltrate and synovial fluid (SF) levels of cytokines in patients with RA according to the presence or absence of ACPA in serum. METHODS: A cross-sectional study in a single center including consecutive RA patients was performed. Patients were defined as 'ACPA negative' if serum was negative to two different ACPAs [second generation commercial anti-cyclic citrullinated peptide antibodies (CCP2) and chimeric fibrin/filaggrin citrullinated antibodies]. Parallel synovial tissue (ST) biopsies and SF were obtained by knee arthroscopy. Synovial cell infiltrate and endothelial cells were analyzed by immunohistochemistry and SF levels of Th1, Th2, Th17 and pro-inflammatory cytokines by Quantibody(R) Human Array. RESULTS: A total of 83 patients underwent arthroscopy, with a mean age of 55.9 ± 12 years, and mean disease duration of 45 months (interquartile range, IQR 10.8 to 122). 62% were female and 77% were ACPA positive. No significant differences were found in clinical variables, acute phase reactants, synovial cell infiltrate or lymphoid neogenesis (LN) between ACPA positive and negative patients. However ACPA positive patients had significantly higher levels of IL-1β, IL-10, IL-17 F and CC chemokine ligand 20 (CCL-20) than ACPA negative patients. CONCLUSIONS: In our cohort of patients with RA no significant differences were found in synovial cell infiltrate or synovial LN according to ACPA status. However, ACPA positive patients had higher levels of T-cell derived and pro-inflammatory cytokines than ACPA negative patients. As systemic and local inflammation was similar in the two groups, these findings support a distinct synovial physiopathology. BioMed Central 2013 2013-11-07 /pmc/articles/PMC3978623/ /pubmed/24485167 http://dx.doi.org/10.1186/ar4372 Text en Copyright © 2013 Gómez-Puerta et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gómez-Puerta, José A
Celis, Raquel
Hernández, M Victoria
Ruiz-Esquide, Virginia
Ramírez, Julio
Haro, Isabel
Cañete, Juan D
Sanmartí, Raimon
Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title_full Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title_fullStr Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title_full_unstemmed Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title_short Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
title_sort differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978623/
https://www.ncbi.nlm.nih.gov/pubmed/24485167
http://dx.doi.org/10.1186/ar4372
work_keys_str_mv AT gomezpuertajosea differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT celisraquel differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT hernandezmvictoria differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT ruizesquidevirginia differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT ramirezjulio differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT haroisabel differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT canetejuand differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients
AT sanmartiraimon differencesinsynovialfluidcytokinelevelsbutnotinsynovialtissuecellinfiltratebetweenanticitrullinatedpeptideproteinantibodypositiveandnegativerheumatoidarthritispatients